Skip to content

Role of Vidarikandadi Granules in Karshya (Underweight) In Children

A Single Arm Clinical Study To EvaluateThe Efficacy Of Vidarikandadi Granules In The Management Of Karshya (Underweight) In Children - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069210
Enrollment
45
Registered
2024-06-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E639- Nutritional deficiency, unspecified

Interventions

None listed

Sponsors

Dr Vishwajeet Nandkumar Pawar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)The patients of age from 1 year to 12 years 2)Patient having signs & symptoms of Karshya i.e Kshudha mandya (Loss of Appetite), Daurbalya (Generalised weakness), Shushka sphika Udar Greeva (wasting of muscle ), State of hunger (Kshudha), Constipation (Badhamalkoshtata) 3)Children whose parents are ready to participate in the clinical trial by giving informed written Consent

Exclusion criteria

Exclusion criteria: 1)Patients with congenital anomalies 2)Patients suffering from any infectious disease 3)Patients having obstructive pathology / surgical etiopathology 4)Parents of children who are not willing for treatment 5)Severe illnesses of systemic disorder and severe malnourished children

Design outcomes

Primary

MeasureTime frame
Improvement in weight of childrenTimepoint: 0th 20th 40th and 60th day

Secondary

MeasureTime frame
To study the safety & adverse effect of Vidarikandadi Granules in karshya (underweight) in childrenTimepoint: 0th 20th 40th And 60th day

Countries

India

Contacts

Public ContactDr Sandip Daberao

Dr. D. Y. Patil College of Ayurved & Research Centre, Pimpri, Pune-411 018 (Maharashtra) India

dr.deep901@gmail.com9545402018

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026